Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CMND
CMND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMND News
Clearmind's Drug Clinical Trial Achieves Success
13h ago
Newsfilter
Trump Signs Executive Order to Accelerate Psychedelic Research
13h ago
stocktwits
Trump Administration to Examine Safety of Psychedelic Drug for PTSD
2d ago
Yahoo Finance
Trump Administration to Examine Ibogaine Research for PTSD Funding
4d ago
stocktwits
Clearmind Medicine's CMND-100 Trial Receives Positive DSMB Recommendation
4d ago
NASDAQ.COM
Clearmind Receives Positive Recommendation for CMND-100 Trial
5d ago
Newsfilter
Clearmind's Drug Trial Achieves Primary Endpoint
6d ago
Newsfilter
Clearmind Medicine Reports Positive Progress in AUD Drug Trial
Mar 31 2026
NASDAQ.COM
Clearmind Advances Clinical Trial for Alcohol Use Disorder
Mar 30 2026
Newsfilter
Clearmind Files Patent Application in India for Next-Gen Psychedelic Compounds
Mar 27 2026
Newsfilter
Clearmind Unveils Patent for Innovative Weight Loss Therapy
Mar 10 2026
Yahoo Finance
Clearmind's CMND-100 Clinical Trial Receives Approval
Mar 04 2026
Newsfilter
Clearmind's MEAI Drug Breakthrough in Obesity Treatment
Feb 19 2026
PRnewswire
Clearmind's MEAI Drug Breakthrough in Obesity Treatment
Feb 19 2026
Newsfilter
Clearmind Medicine Reports Positive Clinical Trial Results
Feb 09 2026
NASDAQ.COM
Clearmind Reports Positive Safety Results for AUD Drug in Phase I/IIa Trial
Feb 09 2026
Newsfilter
Show More News
